Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice

T. Giraldi, P. J. Houghton, D. M. Taylor, C. Nisi

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Two dimethyltriazenoimidazoles, DTIC and BRL 51308, and a benzenoid dimethyltriazene, CB 10286, have been examined for their effects in mice bearing Lewis lung carcinoma. A slight reduction of primary tumor growth was found after treatment with DTIC and BRL 51308, whereas CB 10286 caused no significant effect. On the contrary, all the tested compounds sharply reduced the number of lung metastases and also resulted in a high proportion of animals free of metastases at death. No significant cytotoxic effect of the triazenes was observed in small established pulmonary tumors, as determined by evaluating the effects of treatment on the fractional incorporation of 3H-TdR into DNA of the lung colonies. These results are in contrast to those obtained with a purely cytotoxic agent, cyclophosphamide, and indicate that all three triazene derivatives tested have selective antimetastatic properties.

Original languageEnglish (US)
Pages (from-to)721-725
Number of pages5
JournalCancer Treatment Reports
Issue number5
StatePublished - 1978
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Antimetastatic action of some triazene derivatives against the Lewis lung carcinoma in mice'. Together they form a unique fingerprint.

Cite this